 | Up a level |
Bausch, Birke; Schiavi, Francesca; Ni, Ying; Welander, Jenny; Patocs, Attila; Ngeow, Joanne; Wellner, Ulrich; Malinoc, Angelica; Taschin, Elisa; Barbon, Giovanni; Lanza, Virginia; Söderkvist, Peter; Stenman, Adam; Larsson, Catharina; Svahn, Fredrika; Chen, Jin-Lian; Marquard, Jessica; Fraenkel, Merav; Walter, Martin Alexander; Peczkowska, Mariola; ... (2017). Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention. JAMA oncology, 3(9), pp. 1204-1212. American Medical Association 10.1001/jamaoncol.2017.0223
Hentschel, Michael; Rottenburger, Christof; Boedeker, Carsten C; Neumann, Hartmut P H; Brink, Ingo (2012). Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas? Clinical nuclear medicine, 37(2), e24-9. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/RLU.0b013e318238f550
